These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 34260978)

  • 21. Prognosis and causes of death of patients with acute exacerbation of fibrosing interstitial lung diseases.
    Salonen J; Purokivi M; Bloigu R; Kaarteenaho R
    BMJ Open Respir Res; 2020 Apr; 7(1):. PubMed ID: 32265195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The diagnostic value of the bronchoalveolar lavage in interstitial lung diseases.
    Efared B; Ebang-Atsame G; Rabiou S; Diarra AS; Tahiri L; Hammas N; Smahi M; Amara B; Benjelloun MC; Serraj M; Chbani L; El Fatemi H
    J Negat Results Biomed; 2017 Mar; 16(1):4. PubMed ID: 28245857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAL findings in idiopathic nonspecific interstitial pneumonia and usual interstitial pneumonia.
    Veeraraghavan S; Latsi PI; Wells AU; Pantelidis P; Nicholson AG; Colby TV; Haslam PL; Renzoni EA; du Bois RM
    Eur Respir J; 2003 Aug; 22(2):239-44. PubMed ID: 12952254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
    Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
    Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
    [No Abstract]   [Full Text] [Related]  

  • 26. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
    Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
    Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.
    Suga M; Iyonaga K; Ichiyasu H; Saita N; Yamasaki H; Ando M
    Eur Respir J; 1999 Aug; 14(2):376-82. PubMed ID: 10515417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study.
    Abe M; Tsushima K; Ishii D; Shikano K; Yoshioka K; Sakayori M; Suzuki M; Hirasawa Y; Ishiwata T; Kawasaki T; Ikari J; Terada J; Tatsumi K
    Adv Respir Med; 2021; 89(2):101-109. PubMed ID: 33881153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-life experiences in a single center: efficacy of pirfenidone in idiopathic pulmonary fibrosis and fibrotic idiopathic non-specific interstitial pneumonia patients.
    Feng H; Zhao Y; Li Z; Kang J
    Ther Adv Respir Dis; 2020; 14():1753466620963015. PubMed ID: 33070705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies.
    Hoffmann T; Teichgräber U; Förster M; Oelzner P; Kroegel C; Renz D; Weise T; Böttcher J; Schulze PC; Wolf G; Franz M; Pfeil A
    Arthritis Res Ther; 2024 Jul; 26(1):142. PubMed ID: 39075618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
    Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
    Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
    Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
    Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
    Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Corticosteroid responsiveness in patients with acute exacerbation of interstitial lung disease admitted to the emergency department.
    Jang HJ; Yong SH; Leem AY; Lee SH; Kim SY; Lee SH; Kim EY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
    Sci Rep; 2021 Mar; 11(1):5762. PubMed ID: 33707643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoalveolar lavage fluid and progression of scleroderma interstitial lung disease.
    De Santis M; Bosello SL; Peluso G; Pinnelli M; Alivernini S; Zizzo G; Bocci M; Capacci A; La Torre G; Mannocci A; Pagliari G; Varone F; Pistelli R; Danza FM; Ferraccioli G
    Clin Respir J; 2012 Jan; 6(1):9-17. PubMed ID: 21801327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute exacerbation of interstitial lung disease after procedures.
    Amundson WH; Racila E; Allen T; Dincer HE; Tomic R; Bhargava M; Perlman DM; Kim HJ
    Respir Med; 2019 Apr; 150():30-37. PubMed ID: 30961948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.